Canlyniadau Chwilio - Persson, Frederik

Empagliflozin reduces albuminuria—a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial gan Borg, Rikke, Persson, Frederik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Diagnosis of diabetic kidney disease: state of the art and future perspective gan Persson, Frederik, Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A narrative review of new treatment options for chronic kidney disease in type 2 diabetes gan Persson, Frederik, Borg, Rikke, Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Direct renin inhibition in chronic kidney disease gan Persson, Frederik, Rossing, Peter, Parving, Hans-Henrik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease gan Persson, Frederik, Frimodt-Møller, Marie, Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Mitigating risk of aldosterone in diabetic kidney disease gan Frimodt-Møller, Marie, Persson, Frederik, Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Tissue Renin–Angiotensin Systems: A Unifying Hypothesis of Metabolic Disease gan Skov, Jeppe, Persson, Frederik, Frøkiær, Jørgen, Christiansen, Jens Sandahl

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review gan Persson, Frederik, Lindhardt, Morten, Rossing, Peter, Parving, Hans-Henrik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes gan Theilade, Simone, Lajer, Maria, Persson, Frederik, Joergensen, Christel, Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Linking Kidney and Cardiovascular Complications in Diabetes—Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture gan Rossing, Peter, Persson, Frederik, Frimodt-Møller, Marie, Hansen, Tine Willum

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Discrepancy Between Tonometric Ambulatory and Cuff‐Based Office Blood Pressure Measurements in Patients With Type 1 Diabetes gan Theilade, Simone, Lajer, Maria, Joergensen, Christel, Persson, Frederik, Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria gan Rathcke, Camilla Noelle, Persson, Frederik, Tarnow, Lise, Rossing, Peter, Vestergaard, Henrik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Is Time-Restricted Eating Safe in the Treatment of Type 2 Diabetes?—A Review of Intervention Studies gan Uldal, Sarah, Clemmensen, Kim Katrine Bjerring, Persson, Frederik, Færch, Kristine, Quist, Jonas Salling

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of large weight reductions on measured and estimated kidney function gan von Scholten, Bernt Johan, Persson, Frederik, Svane, Maria S., Hansen, Tine W., Madsbad, Sten, Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy gan Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Aliskiren in Combination with Losartan Reduces Albuminuria Independent of Baseline Blood Pressure in Patients with Type 2 Diabetes and Nephropathy gan Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function gan Petrykiv, Sergei, Sjöström, C. David, Greasley, Peter J., Xu, John, Persson, Frederik, Heerspink, Hiddo J.L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes – A comparative study of two ma... gan Broedbaek, Kasper, Køster-Rasmussen, Rasmus, Siersma, Volkert, Persson, Frederik, Poulsen, Henrik E., de Fine Olivarius, Niels

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatment gan Zobel, Emilie H., von Scholten, Bernt J., Goldman, Bryan, Persson, Frederik, Hansen, Tine W., Rossing, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Importance of standardizing renal outcomes in clinical trials: illustration by recent SGLT2 inhibitor studies gan van Raalte, Daniël H., Bjornstad, Petter, Heerspink, Hiddo J.L., Persson, Frederik, Cherney, David Z.I.

Cael y testun llawn Cael y testun llawn Cael y testun llawn